| LncRNA Information | ||||||
|---|---|---|---|---|---|---|
| ID | EL0032 | Name | ADAMTS9-AS2 | Aliases | N/A | |
| Species | Homo sapiens | Chromosome | 3 | Start site | 64684909 | |
| End site | 65011468 | Chain | plus | Exon NO. | 6 | |
| Assembly | Ensembl Release 89 | Class | antisense | NCBI accession | NR_038264 | |
| Ensembl | ENSG00000241684 | Sequence | ||||
| Disease | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Disease | Method | Sample | Expression pattern | Dysfunction type | Description | PMID | Source | ||
| non-small cell lung cancer | microarray, qPCR etc. | NSCLC tissue | down-regulated | expression | The expression level of ADAMTS9-AS2, C1401f132 and LINC00312 in NSCLC tumors were indeed significantly down-regulated when compared with those in normal lung tissues, while LINC00673 was significantly up-regulated in NSCLC tumors compared with normal lung tissues.These lncRNAs could be further exploited for the development of useful biomarkers in diagnosis, prognosis and treatment of NSCLC. | 25590602 | Lnc2Cancer | ||
| glioma | qPCR, Western blot, knockdown etc. | glioma tumor tissue, cell lines (T98G, A172, SNB-19 etc.) | down-regulated | regulation | A new tumor suppressor?LncRNA?ADAMTS9-AS2 is regulated by DNMT1 and inhibits migration of glioma cells. | 24833086 | LncRNADisease Lnc2Cancer | ||